Globus Medical, Inc. (GMED) has 20 known insider and institutional holders on record. The largest holder is Clarus Lifesciences I, L.P. with 604,265 shares. Other notable holders include Demski David M and Scavilla Daniel T.
Over the last 12 months, insiders have made 31 transactions in GMED stock — 15 buys (valued at $41.56M) and 8 sells (valued at $6.32M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
GMED Insider Ownership
Top Holder
Clarus Lifesciences I, L.P.
604,265 shares
Buys (12 mo)
15
$41.56M value
Sells (12 mo)
8
$6.32M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Clarus Lifesciences I, L.p. |
10 Percent Owner |
604,265 |
2012-08-02 |
|
| 2 |
Demski David M |
President, CEO |
150,000 |
2022-01-31 |
|
| 3 |
Scavilla Daniel T |
President, CEO |
140,000 |
2025-03-28 |
|
| 4 |
Paul David C |
10 Percent Owner, Officer: Executive Chairman |
100,000 |
2026-01-23 |
|
| 5 |
Pfeil Keith W |
President, CEO |
100,000 |
2026-01-23 |
|
| 6 |
Williams Anthony L |
President |
80,000 |
2019-02-11 |
|
| 7 |
Schwartz Eric |
Senior VP and General Counsel |
40,000 |
2018-01-24 |
|
| 8 |
Huller Kelly |
EVP, Gc, Corporate Secretary |
40,000 |
2026-01-23 |
|
| 9 |
Murphy A Brett |
EVP, International Sales |
40,000 |
2018-02-06 |
|
| 10 |
Baron Richard A |
Senior VP and CFO |
30,000 |
2014-01-27 |
|
| 11 |
Kline Kyle |
Senior Vice President, CFO |
30,000 |
2026-01-23 |
|
| 12 |
Liptak Robert |
Director |
25,000 |
2019-02-11 |
|
| 13 |
Wheeler Kurt |
Director |
25,000 |
2019-02-11 |
|
| 14 |
Zarrilli Stephen T |
Director |
15,000 |
2026-01-23 |
|
| 15 |
Deford John A |
Director |
15,000 |
2026-01-23 |
|
| 16 |
Norwalk Leslie V |
Director |
15,000 |
2026-01-23 |
|
| 17 |
Lemaitre Dan |
Director |
15,000 |
2026-01-23 |
|
| 18 |
Douglas Robert Andrew |
Director |
15,000 |
2026-01-23 |
|
| 19 |
Wolterman Dan |
Director |
15,000 |
2026-01-23 |
|
| 20 |
Davidar David D |
Director |
15,000 |
2026-01-23 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-02-25 |
Huller Kelly |
EVP, Gc, Corporate Secretary |
Informative Sell |
20,000 |
$94.50 |
$1.89M |
| 2026-02-12 |
Huller Kelly |
EVP, Gc, Corporate Secretary |
Option Exercise (Sell) |
10,000 |
$45.64 |
$456.4K |
| 2026-01-21 |
Kline Kyle |
Senior Vice President, CFO |
RSU Award |
30,000 |
$94.15 |
$2.82M |
| 2026-01-21 |
Huller Kelly |
EVP, Gc, Corporate Secretary |
RSU Award |
40,000 |
$94.15 |
$3.77M |
| 2026-01-21 |
Pfeil Keith W |
President, CEO |
RSU Award |
100,000 |
$94.15 |
$9.42M |
| 2026-01-21 |
Wolterman Dan |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2026-01-21 |
Paul David C |
10 Percent Owner, Officer: Executive Chairman |
RSU Award |
100,000 |
$94.15 |
$9.42M |
| 2026-01-21 |
Davidar David D |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2026-01-21 |
Norwalk Leslie V |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2026-01-21 |
Lemaitre Dan |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2026-01-21 |
Deford John A |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2026-01-21 |
Douglas Robert Andrew |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2026-01-21 |
Rhoads Ann D |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2026-01-21 |
Zarrilli Stephen T |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2026-01-21 |
Tobin James R |
Director |
RSU Award |
15,000 |
$94.15 |
$1.41M |
| 2025-12-01 |
Kline Kyle |
Senior Vice President, CFO |
Option Exercise (Sell) |
4,896 |
$63.68 |
$311.78K |
| 2026-01-08 |
Kline Kyle |
Senior Vice President, CFO |
Informative Sell |
3,594 |
$101.10 |
$363.35K |
| 2026-01-08 |
Norwalk Leslie V |
Director |
Informative Sell |
2,000 |
$101.10 |
$202.2K |
| 2025-01-02 |
Davidar David D |
Director |
Gift (Given) |
6,100 |
- |
- |
| 2025-12-12 |
Norwalk Leslie V |
Director |
Informative Sell |
4,000 |
$88.85 |
$355.4K |
| 2025-12-08 |
Paul David C |
10 Percent Owner, Officer: Executive Chairman |
Option Exercise (Sell) |
34,375 |
$25.52 |
$877.25K |
| 2025-12-01 |
Kline Kyle |
Senior Vice President, CFO |
Option Exercise (Sell) |
5,000 |
$64.44 |
$322.2K |
| 2025-11-25 |
Huller Kelly |
SVP, Gc, Corporate Secretary |
Option Exercise (Sell) |
7,500 |
$25.96 |
$194.7K |
| 2025-11-12 |
Davidar David D |
Director |
Option Exercise (Sell) |
25,000 |
$25.52 |
$638K |
| 2025-11-11 |
Zarrilli Stephen T |
Director |
Informative Sell |
25,000 |
$84.29 |
$2.11M |
